Abstract:Phosphoinositide signalling molecules interact with a plethora of effector proteins to regulate cell proliferation and survival, vesicular trafficking, metabolism, actin dynamics and many other cellular functions. The generation of specific phosphoinositide species is achieved by the activity of phosphoinositide kinases and phosphatases, which phosphorylate and dephosphorylate, respectively, the inositol headgroup of phosphoinositide molecules. The phosphoinositide phosphatases can be classified as 3-, 4- and 5-phosphatases based on their specificity for dephosphorylating phosphates from specific positions on the inositol head group. The SAC phosphatases show less specificity for the position of the phosphate on the inositol ring. The phosphoinositide phosphatases regulate PI3K/Akt signalling, insulin signalling, endocytosis, vesicle trafficking, cell migration, proliferation and apoptosis. Mouse knockout models of several of the phosphoinositide phosphatases have revealed significant physiological roles for these enzymes, including the regulation of embryonic development, fertility, neurological function, the immune system and insulin sensitivity. Importantly, several phosphoinositide phosphatases have been directly associated with a range of human diseases. Genetic mutations in the 5-phosphatase INPP5E are causative of the ciliopathy syndromes Joubert and MORM, and mutations in the 5-phosphatase OCRL result in Lowe's syndrome and Dent 2 disease. Additionally, polymorphisms in the 5-phosphatase SHIP2 confer diabetes susceptibility in specific populations, whereas reduced protein expression of SHIP1 is reported in several human leukaemias. The 4-phosphatase, INPP4B, has recently been identified as a tumour suppressor in human breast and prostate cancer. Mutations in one SAC phosphatase, SAC3/FIG4, results in the degenerative neuropathy, Charcot-Marie-Tooth disease. Indeed, an understanding of the precise functions of phosphoinositide phosphatases is not only important in the context of normal human physiology, but to reveal the mechanisms by which these enzyme families are implicated in an increasing repertoire of human diseases.

Phosphatidylinositol 4-Kinases and PI4P Metabolism in the Nervous System: Roles in Psychiatric and Neurological Diseases

Inositol Hexakisphosphate Kinase 1 (ip6k1) Regulates Inositol Synthesis in Mammalian Cells

Inositol Synthesis Regulates The Activation Of Gsk-3 Alpha In Neuronal Cells

The expanding spectrum of neurological disorders of phosphoinositide metabolism

Inositol polyphosphate phosphatases in human disease

Differential functions of phosphatidylinositol 4-kinases in neurotransmission and synaptic development

Phosphoinositides: Regulators of Nervous System Function in Health and Disease

Biallelic PI4KA variants cause neurological, intestinal and immunological disease

PI4K2A deficiency causes innate error in intracellular trafficking with developmental and epileptic-dyskinetic encephalopathy

Striking a balance: PIP2 and PIP3 signaling in neuronal health and disease

The inositol phosphate signalling network in physiology and disease

Inositol Pyrophosphates: Signaling Molecules with Pleiotropic Actions in Mammals

Drugging the Phosphoinositide 3-Kinase (PI3K) and Phosphatidylinositol 4-Kinase (PI4K) Family of Enzymes for Treatment of Cancer, Immune Disorders, and Viral/Parasitic Infections

The Role of Inositol Hexakisphosphate Kinase in the Central Nervous System

Roles of PI3K/AKT/GSK3 Pathway Involved in Psychiatric Illnesses

Phosphatidylinositol 3,4-bisphosphate: Out of the shadows and into the spotlight

Phosphatidylinositol-3,4,5-Triphosphate and Cellular Signaling: Implications for Obesity and Diabetes

Elucidating the clinical and genetic spectrum of inositol polyphosphate phosphatase INPP4A-related neurodevelopmental disorder

Inhibition of lipid kinase PIKfyve reveals a role for phosphatase Inpp4b in the regulation of PI(3)P-mediated lysosome dynamics through VPS34 activity

The Importance of Phosphoinositide 3-Kinase in Neuroinflammation

Research progress of phosphatidylinositol 4-kinase and its inhibitors in inflammatory diseases